UroGen Pharma
URGN
URGN
84 hedge funds and large institutions have $347M invested in UroGen Pharma in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 41 increasing their positions, 13 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
16
Increased
41
Reduced
13
Closed
14
Calls
$1.63M
Puts
$2.26M
Net Calls
-$630K
Net Calls Change
-$1.52M
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$17.8M |
| 2 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$10M |
| 3 |
WCM
Wildcat Capital Management
New York
|
+$5.07M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$4.01M |
| 5 |
Goldman Sachs
New York
|
+$1.65M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$51.5M |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$8.05M |
| 3 |
HCM
Highline Capital Management
New York
|
-$3.26M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.38M |
| 5 |
AI
Atom Investors
Austin,
Texas
|
-$2.26M |
